HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Da-Jun Yang Selected Research

pelcitoclax

1/2021Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Da-Jun Yang Research Topics

Disease

11Neoplasms (Cancer)
10/2022 - 08/2003
4Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2017
4Lymphoma (Lymphomas)
12/2019 - 01/2008
3Neoplasm Metastasis (Metastasis)
10/2022 - 01/2020
3Carcinogenesis
10/2022 - 08/2003
3Colonic Neoplasms (Colon Cancer)
10/2022 - 01/2018
2Adenocarcinoma
05/2018 - 01/2017
2Ovarian Neoplasms (Ovarian Cancer)
03/2018 - 01/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Esophageal Squamous Cell Carcinoma
01/2021
1Nasopharyngeal Carcinoma
01/2021
1Burkitt Lymphoma (Burkitt's Lymphoma)
12/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Bites and Stings (Sting)
01/2017
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2012
1Leukemia
04/2012
1Lymphoid Leukemia
04/2012
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2012
1Multiple Myeloma
02/2009
1Hematologic Neoplasms (Hematological Malignancy)
11/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2008
1Breast Neoplasms (Breast Cancer)
08/2003

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
10/2022 - 11/2008
3APG-1387IBA
03/2018 - 01/2018
3GossypolIBA
04/2012 - 01/2008
2Messenger RNA (mRNA)IBA
10/2022 - 02/2022
2Phosphotransferases (Kinase)IBA
02/2022 - 01/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2018 - 01/2018
2apogossypoloneIBA
07/2009 - 02/2009
1RNA Splicing FactorsIBA
10/2022
1RNA (Ribonucleic Acid)IBA
10/2022
1MicroRNAs (MicroRNA)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1LuciferasesIBA
01/2021
1GemcitabineFDA Link
01/2021
1pelcitoclaxIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1ibrutinibIBA
01/2021
1RamucirumabIBA
01/2020
1NivolumabIBA
01/2020
1Trifluridine (Viroptic)FDA LinkGeneric
01/2020
1BM-1197IBA
12/2019
1SincalideFDA Link
05/2018
1Caspase 8 (Caspase-8)IBA
03/2018
1Biological ProductsIBA
01/2018
1Sorafenib (BAY 43-9006)FDA Link
01/2018
1Epidermal Growth Factor (EGF)IBA
01/2017
1Trastuzumab (Herceptin)FDA Link
01/2017
1ParaffinIBA
01/2017
1Formaldehyde (Formol)FDA Link
01/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2012
1Acetates (Acetic Acid Esters)FDA Link
04/2012
1Apoptosis Regulatory ProteinsIBA
01/2008
1Tyrosine (L-Tyrosine)FDA Link
08/2003
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2003
1ErbB-2 ReceptorIBA
08/2003
1N-(4-ethoyphenol)-2-hydroxy- acid amideIBA
08/2003

Therapy/Procedure

4Therapeutics
01/2021 - 01/2017
3Drug Therapy (Chemotherapy)
01/2021 - 05/2018
1Heterologous Transplantation (Xenotransplantation)
01/2021
1Immunotherapy
01/2021
1Aftercare (After-Treatment)
02/2009